Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, SE-751 85 Uppsala, Sweden.
BMC Cancer. 2012 Aug 29;12:378. doi: 10.1186/1471-2407-12-378.
MicroRNAs (miRNAs) and their role during tumor development have been studied in great detail during the last decade, albeit their expression pattern and regulation during normal development are however not so well established. Previous studies have shown that miRNAs are differentially expressed in solid human tumors. Platelet-derived growth factor (PDGF) signaling is known to be involved in normal development of the brain as well as in malignant primary brain tumors, gliomas, but the complete mechanism is still lacking. We decided to investigate the expression of the oncogenic miR-21 during normal mouse development and glioma, focusing on PDGF signaling as a potential regulator of miR-21.
We generated mouse glioma using the RCAS/tv-a system for driving PDGF-BB expression in a cell-specific manner. Expression of miR-21 in mouse cell cultures and mouse brain were assessed using Northern blot analysis and in situ hybridization. Immunohistochemistry and Western blot analysis were used to investigate SOX2 expression. LNA-modified siRNA was used for irreversible depletion of miR-21. For inhibition of PDGF signaling Gleevec (imatinib mesylate), Rapamycin and U0126, as well as siRNA were used. Statistical significance was calculated using double-sided unpaired Student's t-test.
We identified miR-21 to be highly expressed during embryonic and newborn brain development followed by a gradual decrease until undetectable at postnatal day 7 (P7), this pattern correlated with SOX2 expression. Furthermore, miR-21 and SOX2 showed up-regulation and overlapping expression pattern in RCAS/tv-a generated mouse brain tumor specimens. Upon irreversible depletion of miR-21 the expression of SOX2 was strongly diminished in both mouse primary glioma cultures and human glioma cell lines. Interestingly, in normal fibroblasts the expression of miR-21 was induced by PDGF-BB, and inhibition of PDGF signaling in mouse glioma primary cultures resulted in suppression of miR-21 suggesting that miR-21 is indeed regulated by PDGF signaling.
Our data show that miR-21 and SOX2 are tightly regulated already during embryogenesis and define a distinct population with putative tumor cell of origin characteristics. Furthermore, we believe that miR-21 is a mediator of PDGF-driven brain tumors, which suggests miR-21 as a promising target for treatment of glioma.
在过去的十年中,人们对 microRNAs(miRNAs)及其在肿瘤发生过程中的作用进行了深入研究,尽管它们在正常发育过程中的表达模式和调控机制尚不完全清楚。先前的研究表明,miRNAs 在实体人类肿瘤中存在差异表达。血小板衍生生长因子(PDGF)信号通路已知参与大脑的正常发育以及恶性原发性脑肿瘤,神经胶质瘤,但完整的机制仍缺乏。我们决定研究致癌 miR-21 在正常小鼠发育和神经胶质瘤中的表达,重点关注 PDGF 信号作为 miR-21 的潜在调节剂。
我们使用 RCAS/tv-a 系统在细胞特异性表达 PDGF-BB 来生成小鼠神经胶质瘤。使用 Northern blot 分析和原位杂交评估 miR-21 在小鼠细胞培养物和小鼠脑中的表达。免疫组织化学和 Western blot 分析用于研究 SOX2 的表达。使用 LNA 修饰的 siRNA 不可逆地耗尽 miR-21。为了抑制 PDGF 信号,使用了 Gleevec(伊马替尼)、Rapamycin 和 U0126 以及 siRNA。使用双侧无配对学生 t 检验计算统计学意义。
我们发现 miR-21 在胚胎和新生期大脑发育过程中高度表达,随后逐渐降低,直到出生后第 7 天(P7)检测不到,这一模式与 SOX2 的表达相关。此外,miR-21 和 SOX2 在 RCAS/tv-a 生成的小鼠脑肿瘤标本中表现出上调和重叠表达模式。不可逆耗尽 miR-21 后,在小鼠原代胶质瘤培养物和人神经胶质瘤细胞系中 SOX2 的表达明显减少。有趣的是,在正常成纤维细胞中,PDGF-BB 诱导 miR-21 的表达,并且在小鼠神经胶质瘤原代培养物中抑制 PDGF 信号导致 miR-21 的抑制,这表明 miR-21 确实受到 PDGF 信号的调控。
我们的数据表明,miR-21 和 SOX2 在胚胎发生过程中已经受到严格调控,并定义了具有潜在肿瘤细胞起源特征的特定群体。此外,我们认为 miR-21 是 PDGF 驱动的脑肿瘤的介质,这表明 miR-21 是治疗神经胶质瘤的有前途的靶标。